What's new
The Integrated Approaches to Testing and Assessment (IATA) Case Studies Project allows countries to share and explore the use of novel methodologies in Integrated Approaches to Testing and Assessment within a regulatory context. One new case that illustrates an assessment workflow based on various types of non-animal test methods was published in 2021. In addition, an updated document that includes considerations of using methods in IATA was also published following the 6th case study review cycle. Since the project was launched in 2015, a total of 24 case studies and six considerations documents have now been finalised. |
INTRODUCTION TO Integrated Approaches to Testing and Assessment (IATA)
What are IATA?IATA are pragmatic, science-based approaches for chemical hazard characterisation that rely on an integrated analysis of existing information coupled with the generation of new information using testing strategies. IATA follow an iterative approach to answer a defined question in a specific regulatory context, taking into account the acceptable level of uncertainty associated with the decision context. There is a range of IATA - from more flexible, non-formalised judgment based approaches (e.g. grouping and read-across) to more structured, prescriptive, rule based approaches [e.g. Integrated Testing Strategy (ITS)]. IATA can include a combination of methods and can be informed by integrating results from one or many methodological approaches [(Q)SAR, read-across, in chemico, in vitro, ex vivo, in vivo] or omic technologies (e.g. toxicogenomics).
Why we use AOPs for IATA?IATA can include a combination of methods and can be informed by integrating results from one or many methodological approaches [(Q)SAR, read-across, in chemico, in vitro, ex vivo, in vivo] or omic technologies (e.g. toxicogenomics). Many testing approaches do not result in a mechanistic understanding of the induced toxicity. This is particularly the case with non-animal testing approaches and understanding the relationship between what is tested and the apical toxicity endpoint being predicted. This is one of the reasons why results from novel approaches are not yet widely and consistently used for regulatory decision-making. An objective and systematic framework is needed to characterise the individual biological and toxicological relevance of novel methods in predicting an adverse effect. The same framework could inform their potential use in combination with other tools and methods to benefit from an integrated approach. The Adverse Outcome Pathway (AOP) concept can be applied as a framework to develop IATA. |
Why IATA?Current regulatory toxicity testing and assessment approaches remain to a large extent based on a checklist of in vivo tests, conducted in accordance with standardised test guidelines or protocols such as OECD Test Guidelines. While this approach has evolved over the past half century, it is unlikely to efficiently meet legislative mandates that require increased numbers of chemical assessments to be undertaken without a concomitant increase in the use of animals and resources. New approaches are necessary to close the gap between the number of chemicals in use and the number assessed to date.
IATA based on the AOP concept |
The Cooperative Chemicals Assessment Programme (CoCAP) was revised in 2014 to enhance the activity of the development and the application of IATA. This programme provides a forum for scientific exchange of approaches on how novel methods are applied to assess the hazard of chemicals, and establish common and best practices for the use of these methods for assessing different types of chemicals. The approaches described in the case studies are applicable in certain regulatory contexts outlined in the case studies. In other regulatory contexts, their fit for purpose would need to be determined.
Description | The OECD has been developing guidance documents and tools for the use of alternative methods such as (Q)SAR, grouping of chemicals, WoE PBK models, and AOPs. There is a need for the investigation of the practical applicability of these methods/tools, as a part of IATA, for different aspects of regulatory decision-making and to build upon case studies and assessment experience across jurisdictions. The IATA Case Studies Project was launched in 2015 under the revised CoCAP to increase experience with the use of IATA by developing case studies, which constitute examples of predictions that are fit for regulatory use. This project reviews case studies submitted from member countries every year. The review results are discussed in a project meeting. The discussion includes the following topics:
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Documents | Considerations from Case Studies on Integrated Approaches for Testing and Assessment (IATA)
Case Studies on Integrated Approaches for Testing and Assessment (IATA)
|
OVERVIEW of Concepts and Available Guidance related to Integrated Approaches to Testing and Assessment (IATA)
The aim of this overview document is to give an overview of existing guidance on Integrated Approaches to Testing and Assessment (IATA) and their component parts. While the number of documents, from different sources, directly or indirectly related to guidance on IATA, is proliferating, the information is fragmented and hard to find.
This overview document is expected to contribute to a common understanding of IATA, by explaining key concepts and providing basic definitions, and to support easier access to existing resources. The document consists of the following sections:
• Chapter 1: Aim of this document.
• Chapter 2: Aims and characteristics of IATA as well as an overview of possible IATA components (information sources).
• Chapter 3: Approach adopted for the mapping of guidance documents, including the inclusion and exclusion criteria applied.
• Chapter 4: Summary of the status of guidance documents, which may include overarching principles, guidance for specific IATA components, or cross-cutting topics such as data quality, assessment of uncertainty and weight of evidence.
• Chapter 5: Based on the findings of Section 4, identification of gaps, duplications or inconsistencies across the guidance landscape, which may inform the development of further guidance or tools.
A list and short description of the mapped guidance documents provides the related guidance documents.
Reporting of Defined Approaches to be used within Integrated Approaches to Testing and Assessment
Description | While an IATA necessarily includes a degree of expert judgement (for example, in the choice of information sources and their weighting) some elements within an IATA can be standardised (i.e. rule- based). Particularly in certain areas of toxicology (e.g. skin sensitisation, skin corrosion and irritation), progress has been made in the development of defined approaches to testing and assessment, in which data generated by non-animal methods are evaluated by means of a fixed data interpretation procedure. To standardise the evaluation of IATA in regulatory decision-making, guidance has been developed to provide principles and templates for reporting defined approaches and individual information sources. A second guidance has been developed to illustrate how the reporting templates can be used to document a number of defined approaches (and information sources used within) in the area of skin sensitisation. |
Documents |
Annex 1 of the second Guidance Document includes the following 12 case studies | |
1 | AOP –based "2 out of 3" weight of evidence / integrated testing strategy ("2 out of 3 – Sens ITS") approach to skin hazard identification |
2 | Sequential Testing Strategy (STS) for hazard identification of skin sensitisers |
3 | A non-testing Pipeline approach for skin sensitisation |
4 | Stacking meta-model for skin sensitisation hazard identification |
5 | Integrated decision strategy for skin sensitisation hazard |
6 | Classification consensus model of decision trees based on in silico descriptors to predict skin sensitisation hazard |
7 | Sensitizer potency prediction based on Key event 1 + 2: Combination of kinetic peptide reactivity data and KeratinoSens™ data |
8 | The artificial neural network model for predicting LLNA EC3 |
9 | Sensitizer potency prediction based on Key event 1+2+3: Bayesian Network ITS/DS for hazard and potency identification of skin sensitizers |
10 | Sequential testing strategy (STS) for sensitising potency classification based on in chemico and in vitro data |
11 | Integrated testing strategy (ITS) for sensitising potency classification based on in silico, in chemico, and in vitro data |
12 | DIP for skin allergy risk assessment (SARA) |
INFORMATION EXCHANGE WEBINAR FOR IATA RELATED PROJECT – NOVEMBER 2017
|
Engage with us
Related Documents